Organizer
Co-Organizers
Supporters
Arrangement
April20-21,2017
Day one morning-Global Industry trends

Day one afternoon to Day two

Stream A -Drug Substance

Stream B --Formulation Design and development

Stream C-- Analytical Development and Support

Stream D-- Regulatory Planning and BE Studies Session

Related Event
DDF Asia 2013

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co., Ltd.
 

        Shijiazhuang Yiling Pharmaceutical Co., Ltd. (hereinafter referred to as “Yiling Pharmaceutical”), a national key high-tech enterprise, was founded on June 16, 1992 by WU Yiling, Academician of Chinese Academy of Engineering. Under WU’s guidance, and with technology and market as its business propellers, the company has created an innovative operation model which covers five business areas including theoretical innovation, clinical practice, scientific research, manufacturing of pharmaceutical products and medical teaching. Over the past 20 years of development, the company, under the business philosophy of carrying forward innovation for the betterment of mankind, has expanded its portfolio to include modern traditional Chinese medicine, chemical pharmacy, and health care products. It is among the top 20 pharmaceuticals listed on the stock market and boasts a net asset of over 5 billion yuan and a market value of about 20 billion yuan (stock code 002603).

http://www.yiling.cn/

Download Brochure

Sponsors
  • Protech Pharmaservices Corporation (PPC)
  • 华运
  • 浙江九洲药业股份有限公司
  • SDL
  • Tegent
  • 博志研新
  • ACDLABS
  • DKSH
  • ViaClinical Ltd
  • cas
  • Brinks, Gilson & Lione Firm
  • Bestcomm Pharmaceutical Co., Ltd
  • suzhouresearch
  • rafflesen
  • dxyen
  • Malvern
  • DXC
  • ikae
  • thermoFisher
  • buchi
Media Partner
  • yg
  • swwy
  • bio1000
  • phex
  • pharma china
  • Insight
  • dxy
  • bio-equip
  • GBI
  • PharmaVision
  • ipt
  • Bioon
  • Lingmed
Contact Us

Luke Xia